A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia

Status:
Completed

Trial end date:
2018-07-31

Target enrollment:

Participant gender:

A study to evaluate the efficacy and safety of an experimental drug (SEP-363856) in acutely psychotic adults with schizophrenia

Phase 2

Sunovion